Looming "patent cliff" drives a surge in drugmaker M&A

11/14/2010 | Philadelphia Inquirer, The

A recent wave of mergers and acquisitions in the drug industry was largely driven by impending revenue loss from a "patent cliff," experts said. "Over the next five years, the pharmaceutical industry will face the sharpest revenue decline in history," according to a December report by Bernstein Research. "Of the top 10 biggest drugs in the world, nine will lose patent protection; of the top 20, 18 will lose protection."

View Full Article in:

Philadelphia Inquirer, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory FDA
Cardinal Health
Columbus, OH
Assistant General Counsel
Cardinal Health
Columbus, OH
Regulatory Affairs Specialist
Stryker
Mahwah, NJ
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA